Correlation Between Eliem Therapeutics and Vaxart
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Vaxart at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Vaxart into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Vaxart Inc, you can compare the effects of market volatilities on Eliem Therapeutics and Vaxart and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Vaxart. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Vaxart.
Diversification Opportunities for Eliem Therapeutics and Vaxart
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Eliem and Vaxart is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Vaxart Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxart Inc and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Vaxart. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxart Inc has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Vaxart go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Vaxart
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.36 times more return on investment than Vaxart. However, Eliem Therapeutics is 1.36 times more volatile than Vaxart Inc. It trades about -0.21 of its potential returns per unit of risk. Vaxart Inc is currently generating about -0.29 per unit of risk. If you would invest 382.00 in Eliem Therapeutics on September 2, 2024 and sell it today you would lose (78.00) from holding Eliem Therapeutics or give up 20.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 90.48% |
| Values | Daily Returns |
Eliem Therapeutics vs. Vaxart Inc
Performance |
| Timeline |
| Eliem Therapeutics |
| Vaxart Inc |
Eliem Therapeutics and Vaxart Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Vaxart
The main advantage of trading using opposite Eliem Therapeutics and Vaxart positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Vaxart can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxart will offset losses from the drop in Vaxart's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |